A new comparative effectiveness review from the Agency for Healthcare Research and Quality examined the benefits and harms of treatments for menopause, including prescription, nonprescription, and complementary therapies.
The report assesses treatments and therapies for the symptoms of menopause, specifically hot flashes, sleep disturbance, psychologic symptoms, urogenital atrophy, and sexual function.
A number of treatments were evaluated, including the use of hormonal therapies (estrogen, alone or with progestogen or androgen), selective serotonin reuptake inhibitors, and eszopiclone.
Both improvement in menopausal symptoms and adverse events were evaluated. The title of the review is “Menopausal Symptoms: Comparative Effectiveness of Therapies.”